A Prospective, Experimental, Multicenter, Open-label, Randomized, Controlled Trial of 3-month Dual Antiplatelet Therapy Followed by Ticagrelor Versus 6-month Dual Antiplatelet Therapy Followed by Ticagrelor After Implanting Bridge

Clinical trial NCT06301776 · UNKNOWN

Trial details

NCT number: NCT06301776
Sponsor: The Fourth Affiliated Hospital of China Medical University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Brain Disease Vertebral Artery Stenosis

Start date: 2023-12-05
Primary completion: 2025-12-31
Enrollment: 560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.